🇺🇸 FDA
Pipeline program

IPN10200

CLIN-10200-454

Phase 2 mab active

Quick answer

IPN10200 for Episodic Migraine is a Phase 2 program (mab) at Ipsen with 1 ClinicalTrials.gov record(s).

Program details

Company
Ipsen
Indication
Episodic Migraine
Phase
Phase 2
Modality
mab
Status
active

Clinical trials